Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.545 USD | -4.68% | -10.11% | -38.02% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.02% | 35Cr | |
+48.89% | 5.87TCr | |
-2.90% | 4.13TCr | |
+36.42% | 3.92TCr | |
-11.22% | 2.74TCr | |
+9.62% | 2.65TCr | |
-22.83% | 1.9TCr | |
+1.67% | 1.25TCr | |
+26.07% | 1.21TCr | |
+21.98% | 1.19TCr |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis : Credit Suisse Raises Organogenesis Holdings' PT to $21 from $9, Expects Continued Success of Commercial Execution Strategy; Keeps Outperform Rating